FDA Warning: Early Deaths Reported in CAR-T Myeloma Trials for J&J and Legend’s Carvykti, Bristol Myers’ Abecma
Washington, D.C. – The FDA has raised concerns over early deaths in clinical trials for CAR-T therapies used to treat myeloma, a type of blood cancer. The trials involved Johnson & Johnson and Legend’s Carvykti, as well as Bristol Myers’ Abecma. The FDA is closely monitoring these trials to ensure patient safety and efficacy of … Read more